Important aspects of osteoarthritis therapy during the COVID-19 pandemic

Chronic systemic inflammation, which is significantly exacerbated by COVID-19 or in conditions of induced physical inactivity, has a great negative effect on the condition of patients with osteoarthritis (OA). Conversely, diseases associated with chronic inflammation (OA, obesity, hypercholesterolem...

Full description

Bibliographic Details
Main Authors: A. M. Lila, A. G. Chuchalin, I. Yu. Torshin, O. A. Gromova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2022-02-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/1261
_version_ 1797876640731103232
author A. M. Lila
A. G. Chuchalin
I. Yu. Torshin
O. A. Gromova
author_facet A. M. Lila
A. G. Chuchalin
I. Yu. Torshin
O. A. Gromova
author_sort A. M. Lila
collection DOAJ
description Chronic systemic inflammation, which is significantly exacerbated by COVID-19 or in conditions of induced physical inactivity, has a great negative effect on the condition of patients with osteoarthritis (OA). Conversely, diseases associated with chronic inflammation (OA, obesity, hypercholesterolemia, bronchial asthma, diabetes mellitus, chronic kidney disease, deficiency of essential micronutrients, etc.) are the background for a more severe course of coronavirus infection. In patients with this comorbid background, infection with SARS-CoV-2 exacerbates chronic systemic inflammation through activation of the NLRP3 inflammasome with the involvement of toll receptors (TLRs). Inflammasome activation is the central mechanism for the formation of the so-called cytokine storm, which leads to pyroptosis of various cell types and the development of multiple organ pathologies characteristic of COVID-19. In addition, induced physical inactivity (immobilization stress) contributes to the development of sarcopenia and increased pain in OA. The chondroprotectors chondroitin sulfate, glucosamine sulfate, undenatured collagen inhibit TLR and inflammasome activation, inhibit muscle mass loss, and may exhibit a direct antiviral effect (inhibit the replication of the SARS-CoV-2 virus).
first_indexed 2024-04-10T02:04:51Z
format Article
id doaj.art-063b8ef64be34e7396eb1daeaed8cbd9
institution Directory Open Access Journal
issn 1996-7012
2310-158X
language Russian
last_indexed 2024-04-10T02:04:51Z
publishDate 2022-02-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj.art-063b8ef64be34e7396eb1daeaed8cbd92023-03-13T08:39:29ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2022-02-0116110811410.14412/1996-7012-2022-1-108-1142455Important aspects of osteoarthritis therapy during the COVID-19 pandemicA. M. Lila0A. G. Chuchalin1I. Yu. Torshin2O. A. Gromova3ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»; Кафедра ревматологии ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава РоссииИнститут фармакоинформатики ФИЦ «Информатика и управление» Российской академии наукИнститут фармакоинформатики ФИЦ «Информатика и управление» Российской академии наукChronic systemic inflammation, which is significantly exacerbated by COVID-19 or in conditions of induced physical inactivity, has a great negative effect on the condition of patients with osteoarthritis (OA). Conversely, diseases associated with chronic inflammation (OA, obesity, hypercholesterolemia, bronchial asthma, diabetes mellitus, chronic kidney disease, deficiency of essential micronutrients, etc.) are the background for a more severe course of coronavirus infection. In patients with this comorbid background, infection with SARS-CoV-2 exacerbates chronic systemic inflammation through activation of the NLRP3 inflammasome with the involvement of toll receptors (TLRs). Inflammasome activation is the central mechanism for the formation of the so-called cytokine storm, which leads to pyroptosis of various cell types and the development of multiple organ pathologies characteristic of COVID-19. In addition, induced physical inactivity (immobilization stress) contributes to the development of sarcopenia and increased pain in OA. The chondroprotectors chondroitin sulfate, glucosamine sulfate, undenatured collagen inhibit TLR and inflammasome activation, inhibit muscle mass loss, and may exhibit a direct antiviral effect (inhibit the replication of the SARS-CoV-2 virus).https://mrj.ima-press.net/mrj/article/view/1261хондропротекцияостеоартритинфламмасоматолл-рецепторыхондроитина сульфат
spellingShingle A. M. Lila
A. G. Chuchalin
I. Yu. Torshin
O. A. Gromova
Important aspects of osteoarthritis therapy during the COVID-19 pandemic
Современная ревматология
хондропротекция
остеоартрит
инфламмасома
толл-рецепторы
хондроитина сульфат
title Important aspects of osteoarthritis therapy during the COVID-19 pandemic
title_full Important aspects of osteoarthritis therapy during the COVID-19 pandemic
title_fullStr Important aspects of osteoarthritis therapy during the COVID-19 pandemic
title_full_unstemmed Important aspects of osteoarthritis therapy during the COVID-19 pandemic
title_short Important aspects of osteoarthritis therapy during the COVID-19 pandemic
title_sort important aspects of osteoarthritis therapy during the covid 19 pandemic
topic хондропротекция
остеоартрит
инфламмасома
толл-рецепторы
хондроитина сульфат
url https://mrj.ima-press.net/mrj/article/view/1261
work_keys_str_mv AT amlila importantaspectsofosteoarthritistherapyduringthecovid19pandemic
AT agchuchalin importantaspectsofosteoarthritistherapyduringthecovid19pandemic
AT iyutorshin importantaspectsofosteoarthritistherapyduringthecovid19pandemic
AT oagromova importantaspectsofosteoarthritistherapyduringthecovid19pandemic